19-4099230-C-G
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_030662.4(MAP2K2):c.890G>C(p.Arg297Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R297Q) has been classified as Uncertain significance.
Frequency
 Genomes: not found (cov: 33) 
Consequence
 MAP2K2
NM_030662.4 missense
NM_030662.4 missense
Scores
 1
 5
 13
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  6.12  
Publications
0 publications found 
Genes affected
 MAP2K2  (HGNC:6842):  (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008] 
MAP2K2 Gene-Disease associations (from GenCC):
- cardiofaciocutaneous syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
 - cardiofaciocutaneous syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - neurofibromatosis-Noonan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Noonan syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MAP2K2 | NM_030662.4  | c.890G>C | p.Arg297Pro | missense_variant | Exon 7 of 11 | ENST00000262948.10 | NP_109587.1 | |
| MAP2K2 | NM_001440689.1  | c.320G>C | p.Arg107Pro | missense_variant | Exon 5 of 9 | NP_001427618.1 | ||
| MAP2K2 | NM_001440688.1  | c.705+1789G>C | intron_variant | Intron 6 of 8 | NP_001427617.1 | 
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 33 
GnomAD3 genomes 
Cov.: 
33
GnomAD4 exome Cov.: 33 
GnomAD4 exome 
Cov.: 
33
GnomAD4 genome  Cov.: 33 
GnomAD4 genome 
Cov.: 
33
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Uncertain 
D 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
T;T 
 Eigen 
 Benign 
 Eigen_PC 
 Benign 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Uncertain 
D;D 
 M_CAP 
 Benign 
D 
 MetaRNN 
 Uncertain 
T;T 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Benign 
L;. 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Benign 
N;N 
 REVEL 
 Benign 
 Sift 
 Benign 
T;T 
 Sift4G 
 Benign 
T;T 
 Polyphen 
B;. 
 Vest4 
 MutPred 
Gain of glycosylation at R297 (P = 0.0059);.;
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.